Scientific Achievement Award in Drug Discovery and Development
Forecasted
Scientific Achievement Award in Drug Discovery and Development honors investigators whose scientific contributions improve drug discovery, advance translational science, or accelerate drug development.
Funder: American Society for Pharmacology and Experimental Therapeutics
Due Dates (Anticipated): September 2027 (Nomination deadline, anticipated)
Funding Amounts: Achievement recognition rather than funding for a proposed research project
Summary: Recognizes ASPET members’ significant scientific contributions to drug discovery, translational science, and drug development.
Key Information: Nominees must be ASPET members; candidates at any career stage are eligible.
Description
The American Society for Pharmacology and Experimental Therapeutics (ASPET) presents this division-sponsored achievement award through its Division for Drug Discovery and Development. It recognizes outstanding investigators who have made significant contributions to drug discovery, translational science, and/or drug development. The award honors scientific accomplishments rather than supporting a proposed research project or future project deliverables.
Contributions may include technologies, methods, or processes that improve drug discovery or enable accelerated drug development. Work in any therapeutic area or therapeutic modality is considered, including small molecules, oligonucleotides, gene therapies, biologics, and drug-device combinations. The award is listed for ASPET members at any career stage.
